Figure 3 Preventive strategies for CSA-AKI

Slides:

Advertisements

Similar presentations

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Combining Functional and Tubular Damage Biomarkers.

Advertisements

A Comparison of the Systems for the Identification of Postoperative Acute Kidney Injury in Pediatric Cardiac Patients Daniel J. Lex, MD, Roland Tóth,

PREDICTIVE VALUE OF CHRONIC KIDNEY DISEASE (CKD) IN ACUTE KIDNEY INJURY (AKI) PRESENTATION IN AN INTENSIVE CARE UNIT (ICU) OF A LOCAL HOSPITAL. José María.

Nat. Rev. Nephrol. doi: /nrneph

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 4 Interplay between acute kidney injury (AKI),

Figure 6 Effects of adiponectin on podocyte function

Risk Index for Postoperative Acute Kidney Injury After Valvular Surgery Using Cardiopulmonary Bypass Takashi Yamauchi, MD, PhD, Shigeru Miyagawa, MD,

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Figure 6 Differences in glycaemic control with the study drug

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Nat. Rev. Nephrol. doi: /nrneph

Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Types of coronary artery calcification

Figure 1 Pulmonary oedema in AKI

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Frederik Persson, Peter Rossing Kidney International Supplements

Figure 7 The efficacy of phosphate-binder therapy

Prediction of severe acute kidney injury after pediatric cardiac surgery with the use of novel biomarkers: A new trend in clinical research and risk stratification

Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)

Figure 5 Risk factor control in the intensive treatment group

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 The network of chronic diseases and their mutual influences

Figure 1 The burden of chronic kidney disease (CKD)

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Podocyte dysfunction is a common feature of renal injury

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Milestones in paediatric acute kidney injury (AKI) research

Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,

Figure 1 Acute kidney injury and chronic kidney disease

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 The continuum of acute kidney injury (AKI),

Figure 4 Model of changes in the serum levels

Update on acute kidney injury after cardiac surgery

Figure 2 The potential effects of nicotinamide adenine

Figure 6 Schematic of an analysis of a new biopsy

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Emerging models of antibody-mediated rejection (ABMR) and

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study Siu-Hin Wan, MD, Joshua P. Slusser, BS, David.

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

A Comparison of the Systems for the Identification of Postoperative Acute Kidney Injury in Pediatric Cardiac Patients Daniel J. Lex, MD, Roland Tóth,

Figure 3 Hypothetical trajectories of acute kidney disease (AKD)

Nat. Rev. Nephrol. doi: /nrneph

Propofol as a panacea for acute kidney injury?

Figure 1 Potential strategy for belatacept-based

Figure 5 The nephron-centric model of renal transplant fibrosis based on the injury-related molecular events observed in biopsy samples in the first year.

Figure 6 Hypothetical effect of starting therapy for autosomal

Figure 6 Combining population-wide and high-risk strategies

Figure 2 Sources of data to characterize the ADPKD clinical phenotype

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Pathophysiological events and preventive

Perioperative Acute Kidney Injury

Low preoperative hepcidin concentration as a risk factor for mortality after cardiac surgery: A pilot study Anja Haase-Fielitz, PharmD, Michael Plaß,

Early intraoperative iron-binding proteins are associated with acute kidney injury after cardiac surgery Nora Choi, MSc, Reid Whitlock, BSc, Jessica.

Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.

Figure 1 Worldwide distribution of disease burden attributable to environmental risks in 2012 Figure 1 | Worldwide distribution of disease burden attributable.

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Perioperative Acute Kidney Injury

Nat. Rev. Cardiol. doi: /nrcardio

Copyright © 2013 Elsevier Inc. All rights reserved.

Potential roles of biomarkers

Incidence of postoperative acute kidney injury in patients with chronic kidney disease undergoing minimally invasive valve surgery Gerson D. Valdez,

Figure 1 Relationships between genetic variants, quantitative traits and diseases Figure 1 | Relationships between genetic variants, quantitative traits.

Presentation transcript:

Figure 3 Preventive strategies for CSA-AKI Figure 3 | Preventive strategies for CSA-AKI. The prevention of cardiac surgery-associated acute kidney injury (CSA-AKI) relies on the identification of high-risk patients using three strategies: analysis of biomarkers, assessment of clinical risk factors and identification of preoperative, intraoperative and postoperative risk factors. In addition, adherence to the Kidney Disease: Improving Global Outcomes (KDIGO) treatment guidelines10 might reduce the risk of AKI. Wang, Y. & Bellomo, R. (2017) Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.119